Obesity is associated with a spectrum of liver abnormalities, known as nonalcoholic fatty liver disease (NAFLD), characterized by an increase in intrahepatic triglyceride (IHTG) content (i.e. steatosis) with or without inflammation and fibrosis (i.e. steatohepatitis).
The diagnostic solution to this massive obesity issue.
https://ferriscan.com/ferrismart/
Ann: Resonance Health Partners with Siemens healthineers, page-201
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
-0.003(4.76%) |
Mkt cap ! $28.15M | |||
| Open | High | Low | Value | Volume |
| 6.2¢ | 6.2¢ | 6.0¢ | $14.11K | 230.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 172270 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 128098 | 1 |
View Market Depth
| Last trade - 12.59pm 07/08/2024 (20 minute delay) ? |
| RHT (ASX) Chart |